Would you switch from weekly cetuximab to cisplatin during definitive chemoRT for locally advanced oropharyngeal SCC?

Community
Company
News
Contact Us
Sign in

Topics: Head and Neck Cancers • Medical Oncology

Patient initially was started on cetuximab due to renal insufficiency of unclear chronicity (uncontrolled hypertension) that significantly improved during treatment.

Related Questions

How do you approach patients with recurrent papillary thyroid cancer following thyroidectomy who now has palpable cervical nodes and underwent neck dissection and RAI?

How do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?

How do you counsel patients and partners of patients with HPV+ cancers regarding the HPV vaccine?

How do you approach patients with node positive sebaceous cell carcinoma of the eyelid for adjuvant chemotherapy and radiation?

How would you approach new dermal mets in a patient who recently finished chemoradiation for head and neck SCC?

What is your approach to counseling patients who require definitive radiation therapy to the head and neck but for whatever reason, cannot/will not undergo recommended extractions?

What is your approach to treat metastatic poorly differentiated thyroid cancer with papillary features?

In a patient with history of successfully treated locally advanced H&N cancer, how do you discern between a metachronous second primary locally advanced lung SCC vs. metastatic head and neck SCC?

In a patient with very advanced head and neck cancer treated with induction chemotherapy and then definitive radiation do you recommend adding concurrent chemotherapy with the radiation?

In what scenario would you recommend induction chemotherapy prior to chemo-radiation in head and neck cancers and what would be the preferred regimen?